These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 493540)

  • 1. Rapid clearance of advanced pelvic carcinomas by low dose rate 252Cf neutron therapy.
    Maruyama Y
    Radiology; 1979 Nov; 133(2):473-5. PubMed ID: 493540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scheduling of hypoxic-tumor therapy using neutron brachytherapy.
    Maruyama Y; Beach JL; Feola J
    Radiology; 1980 Dec; 137(3):775-81. PubMed ID: 6777827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of brachytherapy with californium-252 neutrons versus cesium-137 photons for eradication of bulky localized cervical cancer: single-institution study.
    Maruyama Y; van Nagell JR; Yoneda J; Donaldson E; Gallion H; Higgins R; Powell D; Turner C; Kryscio R
    J Natl Cancer Inst; 1988 Jun; 80(7):501-6. PubMed ID: 3367388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutron and gamma dose distribution for tandem, tandem and ovoid and plaque for intracavitary 252Cf therapy of cervix carcinoma.
    Maruyama Y; Tai DL; Beach JL
    Radiat Med; 1983; 1(3):230-6. PubMed ID: 6390538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Californium-252 neutron curietherapy for advanced cervical cancer.
    Maruyama Y; Bell PR; Yoneda J; Van Nagell JR
    Oncology; 1982; 39(4):209-15. PubMed ID: 7088471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
    Tacev T; Vacek A; Ptácková B; Strnad V
    Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutron brachytherapy is better than conventional radiotherapy in advanced cervical cancer.
    Maruyama Y; Kryscio R; van Nagell JR; Yoneda J; Donaldson E; Hanson M; Beach JL; Feola JM; Martin A; Parker C
    Lancet; 1985 May; 1(8438):1120-2. PubMed ID: 2860334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical study of relative biological effectiveness for cervical carcinoma treated by 252Cf neutrons and assessed by histological tumour eradication.
    Maruyama Y; Feola JM; Wierzbicki J; van Nagell JR; Powell D; Yoneda J
    Br J Radiol; 1990 Apr; 63(748):270-7. PubMed ID: 2112036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of time-dose and fractionation for 252Cf neutrons in preoperative bulky/barrel-cervix carcinoma radiotherapy.
    Maruyama Y; Wierzbicki J
    Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1561-8. PubMed ID: 2262382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of neutron/gamma-ray dose ratios in intracavitary 252Cf neutron therapy.
    Tai DL; Maruyama Y
    Radiology; 1978 Sep; 128(3):795-7. PubMed ID: 674658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cervical cancer clearance after 252Cf neutron brachytherapy versus conventional photon brachytherapy.
    Maruyama Y; Muir W
    Am J Clin Oncol; 1984 Aug; 7(4):347-52. PubMed ID: 6741864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The preliminary report of cervical cancer treated with californium-252 neutron after loading intracavitary radiotherapy].
    Luo G; Zheng C; Shan J
    Zhonghua Fu Chan Ke Za Zhi; 2001 Dec; 36(12):742-4. PubMed ID: 16136896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences.
    Sorbe B; Bohr L; Karlsson L; Bermark B
    Int J Oncol; 2010 Feb; 36(2):371-8. PubMed ID: 20043071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical report on external irradiation combined with californium-252 neutron intraluminal brachytherapy for cervical carcinoma treatment.
    Zhao H; Wang K; Sun J; Geng X; Zhang W
    Tumori; 2007; 93(6):636-40. PubMed ID: 18338506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cure of cervical cancer using 252Cf neutron brachytherapy.
    Maruyama Y; van Nagell JR; Yoneda J; Donaldson ES; Gallion HH; Higgins R; Kryscio RJ
    Strahlenther Onkol; 1990 May; 166(5):317-21. PubMed ID: 2190346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical trial for advanced cervico-vaginal pelvic carcinomas using Californium Cf-252 fast neutron therapy: report of early responses.
    Maruyama Y; Yoneda J; Krolikiewicz H; Mendiondo O; Beach JL; Coffey CW; Thompson D; Wilson LC; Feola J; Van Nagell JR; Donaldson ES; Powell D
    Int J Radiat Oncol Biol Phys; 1980 Dec; 6(12):1629-37. PubMed ID: 6263831
    [No Abstract]   [Full Text] [Related]  

  • 18. Californium-252 brachytherapy combined with external-beam radiotherapy for cervical cancer: long-term treatment results.
    Lei X; Qian CY; Qing Y; Zhao KW; Yang ZZ; Dai N; Zhong ZY; Tang C; Li Z; Gu XQ; Zhou Q; Feng Y; Xiong YL; Shan JL; Wang D
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1264-70. PubMed ID: 21435797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.
    Maruyama Y; Bowen MG; Van Nagell JR; Gallion HH; DePriest P; Wierzbicki J
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):529-34. PubMed ID: 8005811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New understanding from Cf brachytherapy trials and considerations for neutron therapy of bulky gyn carcinoma for future.
    Maruyama Y; Mesina J; Yudelev M; Wierzbicki J; Deppe G; Porter AT
    Strahlenther Onkol; 1994 May; 170(5):253-63. PubMed ID: 8197547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.